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ABSTRACT
AN IN VIVO STUDY OF THE MAMMALIAN MITOTIC KINESIN EG5
SEPTEMBER 2010
ALYSSA D. GABLE, B.S., UNIVERSITY OF MASSACHUSETTS AMHERST
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by: Professor Patricia Wadsworth
During mitosis, replicated chromosomes are equally distributed among two
daughter cells by means of a multi-component machine called the mitotic spindle.
Spindle formation and function has been shown to involve numerous microtubule
associated proteins and molecular motor proteins, including kinesins and dynein. One
such kinesin, the plus-end directed, homotetrameric, Eg5, is involved in centrosome
separation during spindle formation. In vitro, Eg5 crosslinks parallel and antiparallel
microtubules, and localizes to spindle poles and microtubules in vivo. To further
understand the function of Eg5 in mammalian cells, we determined its distribution and
dynamics throughout mitosis using novel cloning techniques, fluorescence recovery after
photobleaching, and total internal reflection fluorescence microscopy. Eg5-GFP was
expressed from a mouse bacterial artificial chromosome to ensure the transgene’s
expression was at or near endogenous levels. Our results confirm that Eg5 colocalizes
with spindle, but not astral, microtubules and is enhanced at the spindle poles during
prometaphase and metaphase. In early anaphase, Eg5 is localized near the poles
transitioning to interzone microtubules with the exception of a 1 µm gap during late
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anaphase. Fluorescence recovery after photobleaching shows that Eg5 is rapidly turning
over throughout mitosis with a recovery half time less than 10 s and extent of recovery
greater than 85%. TIRF microscopy revealed a population of Eg5 that transiently binds
to microtubules with a residency time of less than 6 seconds for all stages of mitosis. Eg5
remained stationary while bound to microtubules with no apparent directional motion.
Treatment of cells expressing mEg5-GFP-LAP with the Eg5 inhibitor, STLC, caused Eg5
to no longer bind to microtubules and remain diffuse within the cell. TIRF microscopy
also revealed Eg5-decorated tracks during interphase, which were abolished by treatment
with STLC or Nocodazole suggesting that Eg5 is present on microtubules in interphase.
Taken together, fluorescence recovery after photobleaching and TIRF microscopy reveal
that Eg5 is highly dynamic in the mammalian spindle throughout mitosis.
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CHAPTER I
INTRODUCTION
Mitosis is the process by which the duplicated genome is equally distributed
between two daughter cells. This process occurs in six stages (prophase, prometaphase,
metaphase, early anaphase, late anaphase, and telophase) which are characterized by
dissolution of the nuclear envelope, MT access to the genetic material, alignment of
chromosomes perpendicular to the pole-pole axis, transport of chromosomes to opposing
ends of the cell, and balanced reformation of the nuclear envelope around each
chromosomal mass, respectively.
If mitosis fails to proceed correctly (i.e. if DNA damage or spindle defects occur),
there may be detrimental consequences, such as cancer (Hartwell and Kastan, 1994).
Cancer is associated with unregulated and uncontrolled cell division. Therefore, in order
to understand the causes behind the disease it is necessary to determine the mechanisms
and players involved in the unperturbed system. Once the differences between normal
cell division and aberrant division of cancer cells are well understood, one can then target
the source of these differences for potential use in cancer therapeutics.
The process of mitosis requires a multi-component structure called the mitotic
spindle. This bipolar spindle consists of a network of centrosomal and kinetochore
microtubules (MTs), MT associated proteins (MAPs), and molecular motor proteins,
which function to ensure proper separation of sister chromatids while maintaining the
bipolarity of the spindle. MTs are dynamic filaments comprised of α- and β-tubulin
dimers typically arranged as 13 protofilaments linked together to form a hollow MT
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structure. Because the monomeric subunits of tubulin dimers are chemically distinct, and
because dimers are arranged in a repetitive head-to-tail fashion, MTs are structurally
polarized. This polarity manifests functionally as a fast-growing plus-end and a slowgrowing minus-end (Bergen and Borisy, 1980) within individual MTs and ultimately as
dynamic instability within the spindle (Mitchison and Kirschner, 1984). Also within the
mitotic spindle, MTs undergo poleward movement both in vivo and in X. laevis egg
extracts, a process that has been termed poleward MT flux (Mitchison, 1989; Sawin and
Mitchison, 1991). MT dynamics and stability are regulated by MAPs and motor proteins.
Structural MAPs bind to the MT lattice whereas motors use ATP hydrolysis to “walk”
toward the plus or minus ends of the MT filament. Some motor proteins can also
catalyze MT disassembly. In mammalian cells, siRNA screens have shown that multiple
kinesins and dynein contribute to spindle formation, chromosome movement, and
cytokinesis (Zhu et al., 2005). Inhibition or depletion of these individual motor proteins
can drastically alter spindle assembly and/or spindle morphology. Because of these
mitotic defects, microtubule associated proteins and motor proteins are being targeted for
possible use in cancer therapeutics (Bhat and Setaluri, 2007).
One well characterized mitotic motor protein is the homotetrameric, plus-end
directed kinesin Eg5, which is involved in separating the two centrosomes during spindle
assembly. Eg5 consists of three domains, a motor head that has ATP binding capability
and a C-terminal tail which has a MT binding domain, linked by a coiled-coil domain (Le
Guellec et al., 1991). Electron micrographs and other structural analyses show that two
Eg5 monomers form a dimer and two dimers bind in an antiparallel manner to form a
homotetramer giving Eg5 an overall dumbbell structure (Kashina et al., 1996). In vitro
2

studies show that the intrinsic bipolarity of Eg5 allows it to crosslink both parallel and
antiparallel MTs and slide apart only those that are antiparallel (Kapitein et al., 2005).
There have been several in vivo studies across various species that explore the
localization, dynamics, and function of Eg5. In both X. laevis and D. melanogaster, Eg5
has been shown to localize to spindle MTs and spindle poles (Sawin et al., 1992;
Cheerambathur et al., 2008). Eg5 remains static in the spindle midzone (Kapoor and
Mitchison, 2001) and moves poleward in the half spindle as a result of an interaction with
the minus-end directed dynein/dynactin complex in X. laevis (Uteng et al., 2008). It has
also been reported in mammalian cells that Eg5 and dynein maintain an antagonistic
relationship; both motors are able to crosslink and slide apart antiparallel MTs in opposite
directions allowing for the maintenance of the bipolarity of the spindle. Inhibition of Eg5
during spindle formation or at metaphase causes a monopolar spindle phenotype or
spindle shortening, respectively (Ferenz et al., 2009). These observations indicate that
Eg5 is an important protein not only for the assembly but for the maintenance of the
bipolar spindle.
Despite these observations, little is known about the dynamics, regulation, and
overall function of Eg5 in mammalian cells. Here we use novel cloning techniques and
various types of fluorescence microscopy to study the localization and dynamics of
endogenously expressed mEg5 in pig kidney epithelial (LLC-Pk1) cells. We used two
different types of fluorescence microscopy to evaluate spatially distinct areas of the
spindle: confocal microscopy to observe the half spindle and total internal reflection
fluorescence (TIRF) microscopy to visualize the spindle midzone. Fluorescence recovery
after photobleaching (FRAP) experiments reveal that Eg5 is extremely dynamic during
3

all stages of mitosis. Using TIRF microscopy, in vivo, we detected a population of Eg5
that transiently binds MTs while remaining stationary during its residency on the MT.
Our results show the importance of using various types of fluorescence microscopy to
study protein dynamics in vivo and suggest a highly dynamic population and a more
stable population of Eg5 coexisting throughout mitosis.
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CHAPTER II
MOUSE EG5-BAC TRANSGENE EXPRESSED AT ENDOGENOUS LEVELS IS
FUNCTIONAL IN MAMMALIAN CELLS
Introduction
Studying protein function in mammalian cells is traditionally accomplished by
transfecting cells with a plasmid containing fluorescently labeled cDNA encoding the
protein of interest expressed off of a constitutive promoter. This method of protein
expression, however, is not the most accurate way to study protein function because the
transgene is under the control of a strong, non-native promoter, typically a viral promoter
such as CMV, which often leads to unregulated expression of the protein. In order to
effectively study the localization and dynamics of Eg5 in vivo, we used newly developed
bacterial artificial chromosome (BAC) technology. BACs are large cloning vectors that
allow large pieces of DNA to be stably inserted (e.g. an entire gene of interest, including
all native regulatory elements) (Bird and Hyman, 2008). By using BACs, not only is
expression of the transgene at or near endogenous levels in the cell, the native mechanism
behind expression regulation is utilized. Genes encoded on BACs can also be mutated
and modified using a bacterial recombination system. The bacterial strain that harbors
the BAC can be transformed with a plasmid that confers the ability to perform
homologous recombination (Zhang et al., 2000; Muyrers et al., 1999) to introduce
fluorescent tags for protein labeling and point or deletion mutations for studying protein
regulation (Bird and Hyman, 2008).
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Here we used BAC technology in order to effectively study the localization and
dynamics of Eg5 in vivo. Through homologous recombination we were able to label
mEg5 with a C-terminal GFP-LAP (localization and purification) tag and create a stable
LLC-Pk1 cell line expressing functional mEg5-GFP-LAP.
Materials and Methods
Materials
All cell culture materials were obtained from either Sigma-Aldrich (St. Louis,
MO) or Invitrogen Life Technologies (Carlsbad, CA) with the exception of Fetal Bovine
Serum, which was obtained from Atlanta Biologicals Inc. (Lawrenceville, GA). Mouse
Eg5 BAC clone RP23-117H14 and BAC cloning reagents were obtained from BACPAC
Resources (Oakland, CA) and Gene Bridges (Heidelberg, Germany), respectively;
electroporation cuvettes were received from Molecular BioProducts, Inc. (San Diego,
CA). The C-terminal GFP-LAP tag (C-term R6K-Amp-LAP) was a gift from the Hyman
Lab (Dresden, Germany). Reagents used for mammalian transfection were obtained from
QIAGEN Inc. (Valencia, CA). Primary and secondary antibodies used for
immunoblotting and immunofluorescence were obtained from the following: Rabbit-antiEg5 (Novus Biologicals, LLC, Littleton, CO), Goat anti-Rabbit IgG Cy3, and Goat antiRabbit IgG Horse Radish Peroxidase (HRP) (Jackson ImmunoResearch Laboratories,
Inc., West Grove, PA). S-agarose beads used for immunoprecipitation were a gift from
the Lee lab (Amherst, MA). All other chemical reagents, unless specified, were obtained
from Sigma-Aldrich (St. Louis, MO).
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Methods
Cell Culture
Pig kidney epithelial (LLC-Pk1) mEg5-GFP-LAP cells were cultured in
F10/OptiMEM with 7.5% fetal bovine serum and antibiotics at 37o C in a 5% CO2
atmosphere. For imaging, cells were plated at appropriate density on glass coverslips 4872 hours prior to imaging.
BAC Cloning
DH10 E. coli host cells harboring mouse Eg5-BAC clone RP23-117H14 were
received as an LB agar stab culture and streaked onto LB agar plates conditioned with
chloramphenicol (CM). The C-terminal GFP-LAP tag was flanked with mEg5 homology
arms

through

PCR

using

forward

primer

5’-

ATCTCTCCATCTCCAAGAGCAGACTGCCGCTTCACACCTCCATAAACCTCGAT
TATGATATTCCAACTACTG-3’ and reverse primer
5’TGGAGTTTCAGGTTGTATTTTAAAGATGACACCCTAAGCCTCAGATCAGCTCA
GAAGAACTCGTCAAGAAG-3’ which were designed based on primers given from the
Mitocheck BACPAC resources website. Recombineering replaced the mEg5 stop codon
with the GFP-LAP tag yielding the mEg5-GFP-LAP construct. All cloning steps were
followed according to Gene Bridges – Counter Selection BAC Modification Kit, Version
3.1 (March 2008). Preparation of cells for electroporation was performed at 4 o C and
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electroporation voltage was consistently 1.8 kV using a MicroPulser Electroporator (BioRad Laboratories, Hercules, CA). mEg5-GFP-LAP tagged BAC DNA was purified by
following NucleoBond BAC 100 (Clontech, Mountain View, CA) maxi prep protocol.
Mammalian Transfection and Western Analysis
LLC-Pk1 cells were plated at a density of 1.0 x 105 cells/well into 6-well plates
and transfected 48 hours after plating with mouse Eg5-GFP-LAP tagged BAC using
Effectene at a 1:25 ratio of DNA to transfection reagent. Cells successfully transfected
were selected in 2.0 g/L G418 for two weeks (Wadsworth et al., 2005). Whole cell
extracts were prepared by lysis in 0.5% SDS, 1 mM EDTA, and protease inhibitors
Aprotinin (0.02mg/mL), Leupeptin (0.01 µg/mL), and Pefabloc (0.1 mg/mL) then
sonicated twice for 10 s, with cooling in between sonications. A sample was saved for
Lowry Protein Determination and extracts were boiled for 5 min after the addition of 6x
SDS sample buffer. Extracts were run on an 8% polyacrylamide gel and then transferred
to Amersham Hypbond-P membrane (GE Healthcare). Blots were probed with a Rabbitanti-Eg5 antibody (1:1000) for 1 hour at room temperature and Goat anti-Rabbit IgG
HRP as a secondary antibody (1:5000) for 1 hour at room temperature. Blots were
detected using chemiluminescence and analyzed for the correct band size and relative
intensity.
Immunoprecipitation
LLC-Pk1 mEg5-GFP-LAP cells were treated with 100 nM Nocodazole ~20 hours
prior to cell extract preparation. Whole cell extracts were prepared as follows: cells were
lysed in 50 mM HEPES, 150 mM NaCl, 1% NP-40, and protease inhibitors Aprotinin
8

(0.04mg/mL), Leupeptin (0.02 µg/mL), and Pefabloc (0.2 mg/mL).

Lysates were

incubated on ice for 10 min with agitation at 5 min and spun for 30 min at 4o C and the
supernatant was stored on ice. S-agarose beads were washed with lysis buffer and the
lysate was added to the washed S-agarose beads. This complex was incubated for 1 hour
at 4o C with rotation. After this incubation, the complex was spun down and the beads
were washed with lysis buffer and centrifuged. Beads were resuspended in SDS sample
buffer and boiled for 3 min.

SDS-PAGE and immunoblotting were performed as

described above.
Immunofluorescence
LLC-Pk1 mEg5-GFP-LAP cells were plated on coverslips and fixed 72 hours
later. Cells were lysed in extraction buffer (80 mM Pipes pH 6.9, 5 mM EGTA, 1 mM
MgSO4, and 0.5% TritonX-100) for 8 s, fixed in 100% MeOH on ice, and rehydrated in
PBS-Tween-Azide. Cells were stained for Eg5 using primary antibody Rabbit-anti-Eg5
(1:1000) for 1 hour at 37o C and secondary antibody Goat-anti-rabbit Cy3 (1:200) for 1
hour at room temperature. Coverslips were mounted on glass slides using Vectashield
mounting medium (Vector Laboratories, Inc., Burlingame, CA) and sealed with nail
polish.
Microscopy
Cells that were fixed and stained for Eg5 were observed and imaged as previously
described (Rusan et al., 2001 and Ferenz et al., 2009). Live cell observation and imaging
were performed using a Zeiss LSM 510 Meta scanning confocal on an Axiovert 200
microscope equipped with a 63x 1.4 NA objective lens. Images were acquired using
9

LSM software with a unidirectional scan speed of 8 and a scan number of 8. All imaging
was performed at 37o C.
Results
mEg5-GFP-LAP is Expressed at Endogenous Levels
Traditional transfection of cDNA often leads to overexpression of the transgene
being introduced into cells. In order to avoid overexpression, we used BAC technology
to GFP-LAP tag mouse Eg5 to ensure endogenous expression levels of the transgene in
mammalian cells, and study the localization and dynamics of Eg5 (Figure 1).
Transfected LLC-Pk1 cells were analyzed by immunoblotting to determine the
expression level of mEg5-GFP-LAP in comparison to endogenous Eg5 (Figure 2). The
blot shows that the expression level of both mEg5-GFP-LAP and endogenous Eg5 are
very similar, thus indicating that the BAC technology is an effective way to express
labeled proteins at endogenous levels.
Initial observations of Eg5 localization were made using a mixed population of
cells transfected with mEg5-GFP-LAP. This mixed population of Eg5 showed similar
localization to what had previously been identified (Sawin et al., 1992, Cheerambathur et
al., 2008) with Eg5 distributed along the mitotic spindle becoming enhanced at the
spindle poles (Figure 3). A minor fraction of cells either overexpressed mEg5-GFP-LAP
or did not express the construct.

Stable cell lines were created and all subsequent

experiments, unless otherwise noted, were conducted using clone 2.
mEg5-GFP-LAP Interacts with Endogenous Eg5 and is Functional
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In order to proceed with the mEg5-GFP-LAP construct it was important to
determine whether or not the construct was tetramerizing with, and thus behaving in a
manner similar to, endogenous Eg5. Because the LAP construct contained an S-peptide
for purification purposes, we were able to pull-down mEg5-GFP-LAP using S-agarose
beads (Figure 4A). If endogenous Eg5 was interacting with mEg5-GFP-LAP, an
immunoblot of the pull-down would show two bands. Cell lysates, both parental (LLCPk1) and experimental (LLC-Pk1 mEg5-GFP-LAP) were incubated with S-agarose and
Ni-agarose (negative control) beads, washed, and run on an SDS-PAGE gel. Samples
were transferred to membrane and detected using an Eg5 antibody. Indeed Figure 4
confirms that mEg5-GFP-LAP is interacting with endogenous Eg5 indicating that Eg5 on
spindle MTs is likely composed of a mixture of co-heterotetramers. Surprisingly the Niagarose beads pulled down a small amount of both endogenous and GFP-LAP tagged
mEg5 which could be due to nonspecific binding to the agarose. To further solidify the
notion that the two populations of Eg5 are interacting, LLC-Pk1 mEg5-GFP-LAP cells
were fixed and stained for Eg5 using a red (Cy3) secondary antibody (Figure 4B). If the
two different fluorophores (GFP and Cy3) colocalize, it would show that both proteins
are present on the same cellular structures indicating interaction. Figure 4B shows
mEg5-GFP-LAP co-localizing with endogenous Cy3 labeled Eg5 during each stage of
mitosis. A final approach to determine that the mEg5-BAC is functional and is not
affecting cell division we counted the percentage of mitotic cells on several fixed
coverslips and compared them to LLC-Pk1 parental control cells (Table I). The mitotic
index of mEg5-BAC transfected cells was 3.4% as compared to 4.0% for the control
cells. These values indicate that the mEg5-GFP-LAP is not affecting mitotic progression.
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Discussion
The BAC cloning technique allows for an improved method for studying proteins
as shown by our results. Our BAC transgene, mouse mEg5-GFP-LAP, is effectively
expressed at or near endogenous levels in LLC-Pk1 cells. The interaction between Eg5
and mEg5-GFP-LAP as shown by the co-immunoprecipitation is important because it is
indicative that these two proteins are forming tetramers suggesting that there is equal
binding of each protein to MTs in the mitotic spindle. The cells harboring the mEg5GFP-LAP transgene are viable and undergo normal mitosis. Using this cloning
technique, further studies of the localization, dynamics, and function of proteins can be
done to a more efficient and accurate level in vivo.
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Figure 1. Schematic overview of BAC cloning technique. The gene responsible for
making proteins capable of homologous recombination (pRed/ET) is inserted into the
bacterial cells harboring the mEg5-BAC and expression of these proteins is induced.
Once induced, the GFP-LAP tag is electroporated into the bacterial cells containing
mEg5-BAC + pRed/ET. Homologous recombination occurs adding the GFP-LAP tag to
the C-terminus of mEg5. Cells are selected for the recombination event, and the DNA is
purified and transfected into LLC-Pk1 cells.
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Figure 2. mEg5-GFP-LAP expression level. (A) Western blot from a mixed population
of LLC-Pk1 cells stained with an antibody against Eg5. Two bands were detected; upper
band contains mEg5-GFP-LAP, lower band contains endogenous Eg5. Bands have the
same relative intensity indicating that mEg5-GFP-LAP is being expressed at endogenous
levels. (B) Western blot showing 11 LLC-Pk1 mEg5-GFP-LAP clones. Upper band
contains mEg5-LAP, lower band contains endogenous Eg5. All other bands may be the
result of nonspecific binding. Clone 2 was used for subsequent experiments.
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Figure 3. mEg5-GFP-LAP expression and localization. LLC-Pk1 cells expressing a
mixed population of mEg5-GFP-LAP show localization of Eg5 to the mitotic spindle
during each stage of mitosis. mEg5-GFP-LAP localizes to spindle MTs and is heavily
enhanced at the spindle poles.
15

Figure 4. mEg5-GFP-LAP interacts with endogenous Eg5 and does not affect cell
viability. (A) mEg5-GFP-LAP Immnoprecipitation. LLC-PK1 cells expressing mEg5GFP-LAP were lysed and extracts were incubated with S-agarose beads. Samples were
washed, resuspended in SDS sample buffer, and analyzed by SDS-PAGE. Samples were
transferred to membrane and detected using an antibody against Eg5. LLC-Pk1 parental
cells and Ni-agarose were used as controls. Blot shows that endogenous Eg5 was pulled
down with mEg5-GFP-LAP indicating interaction. (B) LLC-Pk1 mEg5-GFP-LAP cells
were fixed and stained for Eg5. mEg5-GFP-LAP (bottom) colocalizes with endogenous
Eg5 (middle and top).

16
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CHAPTER III
EG5 LOCALIZATION AND DISTRIBUTION THROUGHOUT MITOSIS
Introduction
The molecular motor Eg5 is an essential mitotic kinesin involved in the formation
and maintenance of the mitotic spindle. During interphase, Eg5 is diffusely cytoplasmic
as observed using either immunofluorescence or epi-fluorescence. Throughout mitosis
Eg5 is found on spindle MTs, both centrosomal and kinetochore, and at the spindle poles
where it accumulates (Sawin et al., 1992; Cheerambathur et al., 2008). Using an LLCPk1 cell line stably expressing mEg5-GFP-LAP and mCherry-α-tubulin, we observed the
localization and distribution of Eg5 in mammalian cells throughout mitosis. We found
the localization of Eg5 to be similar to that of the previously described with some
exceptions during anaphase.
Materials and Methods
Materials
All cell culture materials were obtained from either Sigma-Aldrich (St. Louis,
MO) or Invitrogen Life Technologies (Carlsbad, CA) with the exception of Fetal Bovine
Serum, which was obtained from Atlanta Biologicals Inc. (Lawrenceville, GA). Cells
were plated on MatTek dishes which were obtained from MatTek Corp. (Ashland, MA).
Nucleofection materials were obtained from Lonza (Basel, Switzerland). Hygromycin
for selection was obtained from Invitrogen Life Technologies (Carlsbad, CA). All other
materials unless otherwise noted were obtained from Sigma-Aldrich (St. Louis, MO).
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Methods
Cell Culture
Pig kidney epithelial (LLC-Pk1) mEg5-GFP-LAP + mCherry-α-tubulin cells were
cultured in F10/OptiMEM with 7.5% fetal bovine serum and antibiotics at 37 o C in a 5%
CO2 atmosphere. For imaging, cells were plated at optimum density on glass bottom
MatTek dishes 48-72 hours prior to imaging.
Mammalian Transfection
LLC-Pk1 mEg5-GFP-LAP cells were transfected with 2.0 µg mCherry-α-tubulin
DNA by nucleofection (program X-001). Cells which successfully received the
mCherry-α-tubulin construct were selected for in 0.5 g/L Hygromycin for two weeks and
cloned into stable cell lines (Wadsworth et al., 2005).
Microscopy and Data Analysis
Live cell observation and imaging was performed using a Zeiss LSM 510 Meta
scanning confocal situated on an Axiovert 200 microscope equipped with a 63x 1.4 NA
objective lens. Images were taken at a 488 and 568 nm wavelength using the appropriate
filters and acquired using LSM software with a unidirectional scan speed of 8 and a scan
number of 8.
Linescans were created by drawing a line from one spindle pole to the other and
extracting the fluorescence intensity values for both mEg5-GFP-LAP and mCherry-αtubulin using MetaMorph software (Universal Imaging, Brandywine, PA) and Microsoft
Excel (Microsoft Office 2007). These values were normalized to a maximum intensity of
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1 by dividing all output intensities by the highest fluorescence intensity value. The
normalized values were plotted against spindle pole distance.
Results
Eg5 Colocalizes with MTs Throughout Mitosis
To determine the localization of Eg5 in a mammalian system we used LLC-Pk1
cells stably expressing both mEg5-GFP-LAP and mCherry-α-tubulin (Figure 1A). We
found that Eg5 is localized to spindle MTs throughout mitosis. Interestingly, however,
we noticed that Eg5 did not bind to interzonal MTs during early anaphase whereas in late
anaphase Eg5 accumulated along interzonal MTs with the exception of a ~1 µm gap
where Eg5 was depleted (Figure 1). To further investigate the distribution of Eg5 relative
to tubulin we used MetaMorph imaging software to create linescans spanning the spindle
pole-to-pole distance at each stage of mitosis (Figure 2). In prophase, both Eg5 and
tubulin fluorescence intensities were elevated at spindle poles with a small decrease in
the middle of the centrosome. For metaphase cells, Eg5 had an increased fluorescence
intensity at spindle poles however the overall fluorescence intensity across the spindle
was less than that of tubulin. Early anaphase cells had a higher tubulin fluorescence
intensity relative to Eg5 in the interzone. In late anaphase, the linescan revealed the drop
in Eg5 fluorescence intensity at the center (~ 1µm) of the interzone relative to tubulin
fluorescence. For telophase cells, Eg5 fluorescence rises above that of tubulin at the
midbody where the two cells have pinched apart. The distribution patterns suggest that
Eg5 is spatially and temporally regulated within the mitotic spindle.
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Discussion
Our results show comparable localization of Eg5 in mammalian cells to the
localization previously described (Sawin et al., 1992; Cheerambathur et al., 2008). We
found it interesting, however, that during early anaphase there is an accumulation of Eg5
near the pole which then seems to redistribute along interzonal MTs during late anaphase
with the exception of a 1 µm gap where Eg5 is absent. This suggests that there are other
midzone proteins or complexes of proteins such as the chromosomal passenger complex
(Terada et al., 1998; Gassmann et al., 2004; Maerki et al., 2009) which block Eg5 from
accumulating there. Linescans revealing Eg5 and tubulin fluorescence intensities suggest
that Eg5 is being spatially and temporally regulated throughout mitosis possibly by
phosphorylation by different kinases at the various stages of mitosis. Eg5 has been
shown to be phosphorylated by CDK1 which is important for its association with the
spindle (Blangy et al., 1995) as well as increasing its affinity to MTs in vitro (Cahu et al.,
2008). It is possible that Eg5 becomes phosphorylated by CDK1 during late anaphase
causing it to accumulate to interzonal MTs. It would be interesting to test the
phosphorylation state of Eg5 throughout mitosis to see if its regulation has an effect on its
distribution within the mitotic spindle.
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Figure 5. Eg5 colocalizes with MTs throughout mitosis. LLC-Pk1 cells stably
expressing mEg5-GFP LAP and transiently transfected with mCherry-α-tubulin.
Composite images show Eg5 and tubulin colocalization. Scale bars represent 10 µm.
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Figure 6. Fluorescence intensity profiles of Eg5 and tubulin in LLC-Pk1 cells. Linescans of mEg5-GFP-LAP (green) and mCherry-α-tubulin (red) during prophase (top),
metaphase (second from top), early anaphase (middle), late anaphase (second from
bottom), and telophase (bottom). Line-scans were taken from a line drawn from one pole
to the other. Scale bar represents 10 μm.
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CHAPTER IV
EG5 IS A HIGHLY DYNAMIC MOTOR PROTEIN THROUGHOUT MITOSIS
Introduction
Eg5 is a slow plus-end directed homotetrameric kinesin required for centrosome
separation during mitotic spindle assembly. Although only slightly processive (average
of 8 steps for each processive run; Valentine et al., 2006), Eg5 has been shown in vitro to
be able to act on two antiparallel MTs which it crosslinks and slide them apart (Kapitein
et al., 2005). In vivo, fluorescence speckle microscopy has revealed that Eg5 is very
dynamic during mitosis with apparent transient poleward and anti-poleward runs within
the mitotic spindle (Cheerambathur et al., 2008). Photoactivation experiments have also
revealed poleward movement of Eg5 as a result of an interaction with the minus-end
directed motor complex dynein/dynactin (Uteng et al., 2008).
In this study, we were interested in learning the dynamics of Eg5 in mammalian
LLC-Pk1 cells and in order to do this we used FRAP and TIRF microscopy. FRAP
experiments entail irreversibly photobleaching a protein tagged with a fluorescent marker
and allowing other fluorescently labeled proteins to move into the bleached region. This
method can reveal the percentage of protein that is mobile and the transport coefficients
of that protein such as diffusion and recovery half time (Axelrod et al, 1976). The
diffusion coefficient shows the displacement of protein by Brownian motion over time,
and recovery half time is the time it takes for 50% of the fluorescence to recover after
photobleaching (Lippincott-Schwartz et al., 1999). Here we were able to determine the
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recovery half time and percentage of fluorescence recovery (mobile fraction) which
revealed that Eg5 has a rapid turnover rate throughout mitosis.
In order to try to get a better understanding of Eg5 dynamics in vivo we wanted to
visualize Eg5 at enhanced resolution. To do this we used total internal reflection
fluorescence (TIRF) microscopy. With TIRF microscopy, in principle, when the laser
light reaches the glass surface of a coverslip, at the critical angle, it becomes totally
internally reflected; in addition, a restricted electromagnetic field is produced, which
extends a short distance (~100 nm) into the sample. This evanescent wave can
illuminate the fluorophores within that region. The distance into the cell that is
illuminated by the evanescent wave is dependent on the refractive indices of the glass
substrate, medium in between the glass and cells, and the cytoplasm of the cell as well as
the distance between the glass substrate and cells (Reichert and Truskey, 1990). By using
TIRF microscopy we were able to observe regions of the spindle where Eg5 has been
proposed to localize that are otherwise not detectable by the more commonly used widefield or confocal fluorescence microscopy. TIRF revealed Eg5 localization at the spindle
midzone during prometaphase and metaphase and along astral MTs during prophase and
anaphase. Quantitative analysis disclosed a population of Eg5 that transiently binds to
MTs and remains stationary for its residency on the MT. Upon treatment with STLC, an
Eg5 inhibitor, Eg5 portrayed a more diffusive motion with a shorter MT dwell time
suggesting that it no longer was able to effectively bind to MTs. Taken together, FRAP
and TIRF results show that there are two populations of dynamic Eg5 in the mitotic
spindle throughout mitosis; a fast moving population that turns over rapidly and a slightly
more stable population that binds and unbinds MTs with no apparent movement.
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Materials and Methods
Materials
All cell culture materials were obtained from either Sigma-Aldrich (St. Louis,
MO) or Invitrogen Life Technologies (Carlsbad, Ca) with the exception of Fetal Bovine
Serum, which was obtained from Atlanta Biologicals Inc. (Lawrenceville, GA). Cells
were plated on MatTek dishes which were obtained from MatTek Corp. (Ashland, MA).
Eg5 inhibitor S-Trityl-L-cysteine (STLC) and MT stabilizing drug Paclitaxel (Taxol)
were obtained from Sigma-Aldrich (St. Louis, MO). Unless otherwise noted, all other
materials were obtained from Sigma-Aldrich (St. Louis, MO).
Methods
Cell Culture
Pig kidney epithelial (LLC-Pk1) mEg5-GFP-LAP cells were cultured in
F10/OptiMEM with 7.5% fetal bovine serum and antibiotics at 37 o C in a 5% CO2
atmosphere. For imaging, cells were plated at optimum density on glass bottom MatTek
dishes 48-72 hours prior to imaging. During image acquisition cells were kept in
minimum essential medium (MEM).
FRAP Experiments and Data Analysis
LLC-Pk1 mEg5-GFP-LAP cells were imaged for three frames and the
fluorescence was bleached with 75 iterations of 100% 488 nm laser light in a region
ranging from ~2x2 µm to ~5x5 µm and subsequently imaged every 1.18 s for a total of
60 s using a Zeiss LSM 510 Meta scanning confocal head on an Axiovert 200 microscope
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equipped with a 63x 1.4 NA objective lens. Scan speed was set at a maximum value of
11 with a scan number of 4. Bleach regions were placed around the centrosome in
prophase cells, in the half-spindle near the pole for prometaphase and metaphase cells,
near the pole for early anaphase cells, and at the interzone between the midzone and
spindle pole for late anaphase. For FRAP of mEg5-GFP-LAP in the presence of 100 nM
Taxol, the drug was incubated with cells for 1.5 hours and was present during imaging.
During all experiments cells were maintained in a TempControl 37-2 digital
environmental chamber held constant at 37o C.
Eg5 FRAP analysis was performed using ImageJ software (National Institutes of
Health, Bethesda, MD) and KaleidaGraph (Synergy Software). All FRAP time-lapse
sequences were corrected for spindle movement using the StackReg (rigid body) plug-in
for ImageJ. Aside from the bleach region of interest (ROI) two other ROIs of the same
size were used: one for background subtraction and the other for photobleaching
correction. The mean fluorescence intensity for each ROI throughout the time-lapse
sequence was calculated by ImageJ and placed into an Excel (Microsoft Office, 2007)
worksheet. Fluorescence intensities were corrected for photobleaching, background
subtracted, and normalized so that the fluorescence intensity pre-bleach was 1 a.u. These
values were plotted against time in KaleidaGraph and fit to a single exponential curve
using the equation y = m1*(1-exp(-m0/m2))+m3; m1= 1; m2 = 10; m3 = 0.5. We were
able to use the values obtained from this equation to calculate the percent recovery and
the amount of time it took for half of the fluorescence to recover (t ½ = τ ln 2; where τ is
the output value of m2 from the previous equation).
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TIRF Microscopy and Analysis
TIRF microscopy was performed using a home-built system (Ross Lab,
University of Massachusetts-Amherst). The microscope is a Nikon Ti-E with phase and
differential interference contrast (DIC) microscopy on the transmitted light path equipped
with a 60x 1.4 NA objective. The microscope has an Intenselite XeHg light source and
light guide for illumination in the epi-fluorescence path and dichroic cubes for
visualization in blue, green and red wavelengths. In addition, there are a separate two
sets of dichroic cubes for TIRF illumination. Lasers for TIRF include a green diode laser
(532 nm, 100 mW) and blue diode laser (488 nm, 50 mW). The system is run by Nikon
Elements software. Images were acquired using a Cascade II 512 x 512 pixel camera. A
4x image expansion telescope in front of the camera was also used.
Time-lapse movies were taken using a 34 ms exposure with no shutter delay in
between images. All imaging was performed at 23.5-30o C. For Eg5 inhibition
experiments, cells were treated with 10 µM STLC followed by a 2 hour incubation prior
to imaging (cells were imaged in the presence of STLC). For MT depolymerization
experiments, 10 µM Nocodazole was added to cells expressing mEg5-GFP-LAP and
imaged immediately after addition of drug. During imaging, cells were maintained in
non-CO2 MEM conditioned with 0.3 U/mL Oxyrase oxygen scavenging system (EC
Oxyrase; Oxyrase, Mansfield, OH).
Quantification of TIRF microscopy data was performed using ImageJ software.
Time-lapse movies were processed to yield a single standard deviation maximum
projection. From this maximum projection, multiple 1 pixel-wide lines were drawn along

28

mEg5-GFP-LAP puncta and kymographs were created. From the length of the
fluorescent lines obtained from the kymographs, the dwell time of Eg5 was calculated.
Dwell times smaller than 0.1 s were neglected.
Results
Eg5 Demonstrates Rapid Turnover throughout Mammalian Mitosis
In order to understand Eg5 dynamics in the mitotic spindle we performed FRAP
experiments on LLC-Pk1 cells expressing mEg5-GFP-LAP. We found that Eg5 is highly
dynamic throughout mitosis with half of the mEg5-GFP-LAP fluorescence turning over
within 10 seconds. At all stages of mitosis, the percentage of mEg5-GFP-LAP
fluorescence that recovered was greater than 85%. We photobleached prophase cells at
the centrosome, where Eg5 forms a bright ring of fluorescence, and obtained a recovery
half-time of 7.28 ± 4.26 s. Prometaphase and metaphase cells were bleached in the half
spindle near the pole and recovered within 5.02 ± 1.98 s and 6.0 ± 4.19 s, respectively
(Figure 1A Top). Early anaphase cells were bleached near the pole in a region between
the chromosomes and centrosome (Figure 1A Bottom) and late anaphase cells were
bleached in the interzone. Early anaphase cells had a recovery half time of 8.79 ± 4.0 s.
Interestingly, we found that mEg5-GFP-LAP fluorescence recovered much faster during
late anaphase than other stages of mitosis with a recovery half time of 2.19 ± 0.75 s
(Table I).
To verify that Eg5 dynamics do not require the dynamics of MTs we performed
FRAP experiments on LLC-Pk1 cells expressing GFP-α-tubulin and cells expressing
mEg5-GFP-LAP treated with 100 nM Taxol. We found that during all stages of mitosis,
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α-tubulin turnover was slower than that of Eg5 (Table I). Prometaphase and metaphase
cells turned over with recovery half times of 15.7 ± 6.59 s and 23.5 ± 16.3 s, respectively.
Early anaphase cells recovered within 13.8 ± 7.74 s and late anaphase cells within 10.5 ±
4.95 s. In cells treated with the MT stabilizing drug, Taxol, Eg5 turnover was the same
as control cells at all stages of mitosis (Table I). These results indicate that the rapid
turnover of Eg5 is occurring independently of MT dynamics.
Eg5 Binds Microtubules and Remains Stationary
In order to further understand the rapid dynamics of Eg5 as seen using FRAP, we
used TIRF microscopy which allows for the observation of a population of Eg5 ~ 100 nm
into the cell (Figure 2A). Time-lapse imaging shows a population of Eg5 that rapidly
binds to MTs while remaining static for the time spent on the MT throughout mitosis. By
taking the sum of all of the frames within an image sequence we were able to see Eg5
decorating MT filaments or creating tracks along MTs at all stages of mitosis (Figure
2B). From these maximum projections, we were able to use single puncta of Eg5 to
create kymographs and calculate the time Eg5 spends on MTs (Figure 2C and Table II).
We found the dwell time of Eg5 on astral MTs in prophase to be 4.81 ± 3.98 s. The
dwell time of Eg5 on overlapping MTs in the spindle midzone during prometaphase and
metaphase was 3.90 ± 4.99 s and 5.72 ± 4.08 s, respectively. Anaphase cells were flat
enough to visualize Eg5 along astral MTs as well as a portion of interzone MTs. During
early anaphase, Eg5 dwell time was 5.02 ± 4.40 s. Interestingly, the dwell time of Eg5
during late anaphase decreased to 0.95 ± 0.46 s, consistent with FRAP which showed a
much faster turnover rate for this stage. Surprisingly, cells in interphase revealed MT
tracks decorated with Eg5 as well with a dwell time of 8.73 ± 6.92 s (Figure 3).
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In order to see how Eg5 residence time on MTs would be altered if Eg5 was
inhibited we treated LLC-Pk1 mEg5-GFP-LAP cells with 10 µM STLC. TIRF
microscopy revealed that in cells treated with STLC, Eg5 was unable to effectively bind
MTs. Eg5 appeared to be diffuse throughout the cell with no detectable MT tracks
(Figure 4A). The majority of kymographs created from Eg5 puncta in STLC treated cells
showed mostly diffusive movement of Eg5 or dwell times ≤ 0.1 s (Figure 4B). However
a portion showed Eg5 binding to MTs with a stationary residence time of 2.03 ± 3.12 s
(Table II). Interestingly, in interphase cells treated with STLC there were no detectable
tracks of MTs decorated with Eg5 as there were in control cells (Figure 3). This result
suggests that Eg5 is present on MTs during interphase in contrast to the previous
observation that Eg5 is diffusely cytoplasmic in interphase cells.
Discussion
In the work described here, we performed experiments in mammalian LLC-Pk1
cells using GFP-tagged mouse Eg5, stably expressed at endogenous levels from BACs,
for FRAP and TIRF microscopy and found that Eg5 is highly dynamic throughout
mitosis. Previous studies using FRAP in D. melanogaster showed that Eg5 is highly
dynamic in anaphase with turnover rates comparable to what we observed in mammalian
cells (Cheerambathur et al., 2008). Photoactivation of Eg5 in X. laevis egg extracts has
shown that Eg5 moves toward spindle poles (Uteng et al., 2008), however we could not
detect poleward movement using FRAP. We did find that Eg5 is rapidly turned over near
the spindle poles at all stages of mitosis. It is possible that we could not detect poleward
movement because the size of the bleached region we used (~2 µm x 2 µm) was too small
to be able to visualize directed motion during fluorescence recovery. It is also possible
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that in the two different organisms Eg5 is functioning differently within the spindle; in
the mammalian spindle Eg5 could be rapidly binding and unbinding MTs, which would
show no directed movement.
Using TIRF microscopy in mammalian cells, we were able to study the behavior
of Eg5 at enhanced resolution. We found that Eg5 transiently binds MTs and is
stationary while bound to the MTs. The transient binding of Eg5 to MTs observed using
TIRF suggests that the FRAP turnover was indeed due to binding and unbinding events
rather than movement of Eg5 along MTs. However, the regions of the spindle that were
visualized using TIRF were different than those that were used for FRAP. For FRAP we
bleached the centrosome in prophase, the half spindle in prometaphase and metaphase,
near the pole in early anaphase, and the interzone in late anaphase. In mitotic cells, the
region of the spindle observed using TIRF microscopy was the region of overlapping
MTs at the spindle midzone. If the spatial and temporal regulation of Eg5 is different
among these areas, then the dynamics of Eg5 obtained from TIRF may not explain the
turnover from FRAP. However, previous studies using speckle microscopy (Kapoor and
Mitchison, 2001), which showed a static population of Eg5 in X. laevis relative to MT
flux, and photoactivation (Uteng et al., 2008), which also revealed a population of Eg5
that is static at the spindle midzone, are consistent with the stationary binding events that
we observed using TIRF. Because TIRF was performed on the region of MT overlap in
the spindle, the observed Eg5 is likely to be binding and crosslinking antiparallel MTs.
In vitro studies have shown that Eg5 crosslinks and slides apart antiparallel MTs
(Kapitein et al., 2005). In the spindle, it is possible that Eg5 motor heads are walking in
opposite directions on two antiparallel MTs that it crosslinks, causing its net
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displacement over time to be zero, thus explaining why we saw stationary binding events
in the spindle midzone.
Previous studies using standard fluorescence microscopy techniques suggest that
Eg5 does not bind microtubules during interphase, as a diffuse pattern of Eg5 staining has
been observed (Sawin and Mitchison, 1995). However, our data using TIRF microscopy
suggest that Eg5 is present on interphase MTs. Although we did not directly image MTs,
TIRF microscopy revealed Eg5 decorating what appear to be track-like projections
throughout interphase cells implying that these filamentous lines are MTs. Further
implications of this observation stem from treatment of cells with an Eg5 inhibitor or a
MT depolymerizing drug. In cells incubated with STLC or high concentrations of
Nocodazole (data not shown) the tracks were diminished and Eg5 portrayed diffusive
motion throughout the cytoplasm as shown by the kymographs in figure 4B, indicating
that Eg5 was no longer bound to MTs.
Our data indicates the importance of using various fluorescence microscopy
techniques to study protein localization and dynamics in vivo. TIRF microscopy has
revealed regions of MT overlap in the mitotic spindle coated with Eg5 in mammalian
cells that were previously proposed but not observed using wide-field or confocal
fluorescence microscopy. The techniques used here (BAC cloning, FRAP, and TIRF
microscopy) allowed us to determine mammalian Eg5 localization and dynamics.
However, in order to fully understand Eg5 function in vivo, it is necessary to resolve how
Eg5 is regulated. It has been shown that inhibition of Eg5 phosphorylation at several
sites in various species cause mitotic defects (Blangy et al., 1995; Cahu et al., 2008;
Rapley et al., 2008; Garcia et al., 2009). Using the various techniques described here it
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would be informative and interesting to see how these same phosphorylation mutants
alter the localization and dynamics of Eg5 in a mammalian system.

34

Figure 7. mEg5-GFP-LAP Fluorescence Recovery After Photobleaching. (A) Selected
images from a FRAP time-lapse movie showing one pre-bleach image, and three postbleach images at the indicated times during metaphase (Top) and early anaphase
(Bottom). Scale bar represents 10 μm. (B) Example FRAP recovery curves for
metaphase (Left) and early anaphase (Right). Raw data was normalized and fit to a
single exponential equation using KaleidaGraph.
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Figure 8. Eg5 distribution and dynamics observed using TIRF microscopy. (A)
Schematic diagram depicting in vivo TIRF microscopy. Left: laser light is totally
internally reflected (red arrows) producing an electromagnetic wave approximately 100
nm into the sample (green). Right: region of a metaphase spindle decorated with Eg5 that
is observed using TIRF. (B) Localization of Eg5 as visualized by TIRF microscopy.
Note the difference between the region of the spindle observed using epi-fluorescence
and the region observed by TIRF. (C) Left: histograms of Eg5 dwell times on MTs
throughout mitosis. The distributions show that Eg5 tends to spend less than 5 s on MTs.
Right: selected kymographs showing stationary Eg5 binding events (yellow lines).
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Figure 9. Eg5 is present on MTs during interphase. Top: mEg5-GFP-LAP observed by
wide-field microscopy (left) and TIRF microscopy (right). The track-like distribution of
Eg5 is indicative of MT binding. Bottom: LLC-Pk1 mEg5-GFP-LAP cells treated with
10 µM STLC observed by wide-field fluorescence microscopy (left) and TIRF
microscopy (right). Eg5 no longer creates tracks and is diffuse in the presence of STLC.
TIRF images are the standard deviation of the z-stack maximum projections.
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Figure 10. Treatment of LLC-Pk1 mEg5-GFP-LAP cells with 10 µM STLC causes Eg5
to no longer effectively bind microtubules. (A) LLC-Pk1 mEg5-GFP-LAP cells treated
with 10 µM STLC observed by wide-field fluorescence microscopy (left) and TIRF
microscopy (right). Wide-field fluorescence microscopy shows a monopolar spindle with
a decrease in mEg5-GFP-LAP fluorescence intensity compared to control bipolar
spindles in figure 2B. TIRF microscopy reveals that Eg5 no longer creates tracks in the
presence of STLC indicating that Eg5 can no longer bind microtubules. Scale bar 10 µm.
(B) Histogram showing the distribution of time spent by Eg5 on microtubules in the
presence of STLC. Selected kymographs depicting Eg5 dwell times (yellow lines) in the
presence of STLC. Red arrows indicate Eg5 diffusion within the cell. Horizontal scale
bar 0.5 µm, vertical scale bar 1 s.
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